Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 3 August 2026.
Announcements
5,264
Total raised
£158B
disclosed amounts
This month
£232M
raised so far
Symvan Capital backs Bristol artificial intelligence startup Tikos to address the black box problem.
"We’re excited to support Mike and Don in making AI systems trustworthy and compliant, addressing one of the most urgent challenges in AI. With over a decade of proprietary research, their ability to retrofit explainability and auditability into existing models is game-changing for regulated industries and high-stakes AI applications."
The Series C round was co-led by Parkwalk Advisors and the Boehringer Ingelheim Venture Fund to support international expansion and clinical studies.
"We would like to thank all the investors that participated, including Parkwalk and Boehringer Ingelheim Venture Fund for their continued support, and welcome Hostplus, all of whom recognise the transformative impact that our technology can have on treatment for stroke and lung fibrosis patients. We will continue to harness our position and experience as a European market leader to achieve broad success in the US, helping improve patient care and access to life-changing therapies."
The agritech startup closed a round backed by biotope, Planetary Impact Ventures, and PINC to accelerate its digital tool development.
"Soil is the foundation of our food system, but modern agriculture has strained its health. The soil microbiome holds the key to restoring fertility, resilience, and reducing reliance on synthetic inputs. By unlocking its potential, we can help farmers produce food sustainably while regenerating the land for future generations."
The financing from Sofinnova Partners and Old College Capital will support the launch of precision fibrosis therapeutics.
"Launching Forth Tx through Sofinnova’s biotech accelerator has allowed us to translate years of our multiomics-driven research into precision therapies that we hope will transform patients’ lives. Fibrosis is an area of huge unmet medical need, and I’m delighted to be working with Alex and the Sofinnova team, as well as OCC, to deliver potent, new treatments for patients with fibrosis."
Manchester United defender Diogo Dalot has backed the health supplement provider with over £841k.
"When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalized and tailored specifically to my needs. Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalized nutrition."
